Analysis

The community pharmacist consultation service could see the roll-out of more health checks through pharmacies.

Figures provided by the regulator suggest there may have been a net decrease of 166 community pharmacies last year.

The new GP contract is described as placing additional financial stress on the community pharmacy sector.

The ability of the NHS in England to deliver the Long term Plan is called into question.

England outperforms other home nations in most areas of disease burden.

Pharmacy trade bodies recommend a reduction in the number of LPCs to save money and improve support.

The PDA warns many UK pharmacies are still failing to meet key patient safety standards such as adequate staffing levels.

Since the community pharmacist consultation service launched last year, there have been some unexpected challenges.

The European Court of Justice has upheld a UK decision that GSK and other companies entered an illegal agreement.

Community pharmacies in 24 countries in Europe experienced medicines shortages last year, according to a PGEU report.

An NHS official has denied claims that employment incentives for GP pharmacists will harm community pharmacy.

NHS England & Improvement has been criticised as having “unrealistic” expectations of pharmacists beginning to work in PCNs.

DHSC advises no-deal preparations should cease.

More than one million people a month fail to attend GP appointments.

A recent analysis commissioned by GPhC suggests a worrying number of pharmacy businesses are operating at a deficit.

The final days of 2019 saw influenza activity continuing to increase in the community.

Brine says it would be “madness” for the government to expect pharmacists to do more work for the same or less money.

The Pharmacists’ Defence Association enjoys high levels of support among community pharmacists, according to a CIG Research survey.

With generic shortages now a regular issue, what are pharmacy trade bodies doing to mitigate the situation?

Health promotion in pharmacies “probably” improves patient health outcomes while being cost-effective, says Cochrane.